LifeVantage Co. (NASDAQ:LFVN) Director Raymond B. Greer Sells 8,000 Shares of Stock

LifeVantage Co. (NASDAQ:LFVN) Director Raymond B. Greer sold 8,000 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $20.15, for a total value of $161,200.00. Following the transaction, the director now directly owns 99,288 shares in the company, valued at $2,000,653.20. This trade represents a 7.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

LifeVantage Stock Performance

NASDAQ:LFVN opened at $19.36 on Thursday. The stock has a market capitalization of $242.97 million, a P/E ratio of 34.57 and a beta of 0.84. LifeVantage Co. has a fifty-two week low of $5.22 and a fifty-two week high of $27.38. The company has a 50 day moving average price of $19.53 and a 200 day moving average price of $14.06.

LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be given a dividend of $0.04 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.16 annualized dividend and a dividend yield of 0.83%. LifeVantage’s dividend payout ratio is presently 28.57%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in LFVN. Capital Management Corp VA acquired a new stake in LifeVantage during the 3rd quarter worth approximately $5,073,000. LPL Financial LLC raised its stake in shares of LifeVantage by 301.0% in the fourth quarter. LPL Financial LLC now owns 211,039 shares of the company’s stock valued at $3,700,000 after acquiring an additional 158,405 shares in the last quarter. American Century Companies Inc. boosted its holdings in LifeVantage by 50.5% in the fourth quarter. American Century Companies Inc. now owns 95,552 shares of the company’s stock valued at $1,675,000 after purchasing an additional 32,055 shares during the period. O Shaughnessy Asset Management LLC boosted its holdings in LifeVantage by 56.2% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company’s stock valued at $1,640,000 after purchasing an additional 33,658 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in LifeVantage by 43.9% during the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock worth $1,300,000 after purchasing an additional 22,620 shares in the last quarter. Institutional investors and hedge funds own 35.32% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Lake Street Capital initiated coverage on LifeVantage in a research report on Thursday, December 19th. They issued a “buy” rating and a $26.00 price objective for the company. Craig Hallum started coverage on LifeVantage in a research report on Tuesday, January 14th. They set a “buy” rating and a $35.00 price objective for the company.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.